| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis.
|
Nature
|
2011
|
13.23
|
|
2
|
Human papillomavirus and rising oropharyngeal cancer incidence in the United States.
|
J Clin Oncol
|
2011
|
12.10
|
|
3
|
Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph).
|
Blood
|
2007
|
4.31
|
|
4
|
Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium.
|
Lancet Oncol
|
2006
|
4.13
|
|
5
|
Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium.
|
Blood
|
2008
|
3.81
|
|
6
|
Tumor necrosis factor (TNF) and lymphotoxin-alpha (LTA) polymorphisms and risk of non-Hodgkin lymphoma in the InterLymph Consortium.
|
Am J Epidemiol
|
2010
|
2.86
|
|
7
|
Etiologic heterogeneity among non-Hodgkin lymphoma subtypes.
|
Blood
|
2008
|
2.49
|
|
8
|
Genome-wide association study of follicular lymphoma identifies a risk locus at 6p21.32.
|
Nat Genet
|
2010
|
2.37
|
|
9
|
Marijuana use and the risk of lung and upper aerodigestive tract cancers: results of a population-based case-control study.
|
Cancer Epidemiol Biomarkers Prev
|
2006
|
2.32
|
|
10
|
Alcohol consumption and risk of non-Hodgkin lymphoma: a pooled analysis.
|
Lancet Oncol
|
2005
|
2.27
|
|
11
|
Risk of non-Hodgkin's lymphoma and family history of lymphatic, hematologic, and other cancers.
|
Cancer Epidemiol Biomarkers Prev
|
2004
|
2.19
|
|
12
|
Family history of hematopoietic malignancies and risk of non-Hodgkin lymphoma (NHL): a pooled analysis of 10 211 cases and 11 905 controls from the International Lymphoma Epidemiology Consortium (InterLymph).
|
Blood
|
2006
|
2.15
|
|
13
|
Altered immunity as a risk factor for non-Hodgkin lymphoma.
|
Cancer Epidemiol Biomarkers Prev
|
2007
|
2.11
|
|
14
|
Common genetic variants in proinflammatory and other immunoregulatory genes and risk for non-Hodgkin lymphoma.
|
Cancer Res
|
2006
|
2.06
|
|
15
|
Risk of non-Hodgkin lymphoma (NHL) in relation to germline variation in DNA repair and related genes.
|
Blood
|
2006
|
2.02
|
|
16
|
Tissues from population-based cancer registries: a novel approach to increasing research potential.
|
Hum Pathol
|
2005
|
1.92
|
|
17
|
Hepatitis C and non-Hodgkin lymphoma among 4784 cases and 6269 controls from the International Lymphoma Epidemiology Consortium.
|
Clin Gastroenterol Hepatol
|
2008
|
1.91
|
|
18
|
Organochlorines in carpet dust and non-Hodgkin lymphoma.
|
Epidemiology
|
2005
|
1.89
|
|
19
|
Cigarette smoking and risk of non-Hodgkin lymphoma: a pooled analysis from the International Lymphoma Epidemiology Consortium (interlymph).
|
Cancer Epidemiol Biomarkers Prev
|
2005
|
1.87
|
|
20
|
Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia.
|
Nat Genet
|
2013
|
1.85
|
|
21
|
Hormonal factors and the risk of invasive ovarian cancer: a population-based case-control study.
|
Fertil Steril
|
2004
|
1.81
|
|
22
|
Comparison of pesticide levels in carpet dust and self-reported pest treatment practices in four US sites.
|
J Expo Anal Environ Epidemiol
|
2004
|
1.76
|
|
23
|
Polymorphism of Xeroderma Pigmentosum group G and the risk of lung cancer and squamous cell carcinomas of the oropharynx, larynx and esophagus.
|
Int J Cancer
|
2006
|
1.65
|
|
24
|
Prognostic significance of host immune gene polymorphisms in follicular lymphoma survival.
|
Blood
|
2007
|
1.63
|
|
25
|
GWAS of follicular lymphoma reveals allelic heterogeneity at 6p21.32 and suggests shared genetic susceptibility with diffuse large B-cell lymphoma.
|
PLoS Genet
|
2011
|
1.58
|
|
26
|
Human leukocyte antigen class I and II alleles in non-Hodgkin lymphoma etiology.
|
Blood
|
2010
|
1.56
|
|
27
|
Persistent organochlorine chemicals in plasma and risk of non-Hodgkin's lymphoma.
|
Cancer Res
|
2005
|
1.55
|
|
28
|
Common gene variants in the tumor necrosis factor (TNF) and TNF receptor superfamilies and NF-kB transcription factors and non-Hodgkin lymphoma risk.
|
PLoS One
|
2009
|
1.52
|
|
29
|
Atopic disease and risk of non-Hodgkin lymphoma: an InterLymph pooled analysis.
|
Cancer Res
|
2009
|
1.45
|
|
30
|
Variants at 6q21 implicate PRDM1 in the etiology of therapy-induced second malignancies after Hodgkin's lymphoma.
|
Nat Med
|
2011
|
1.42
|
|
31
|
Ultraviolet radiation, dietary vitamin D, and risk of non-Hodgkin lymphoma (United States).
|
Cancer Causes Control
|
2006
|
1.38
|
|
32
|
Immune-related conditions and immune-modulating medications as risk factors for non-Hodgkin's lymphoma: a case-control study.
|
Am J Epidemiol
|
2005
|
1.36
|
|
33
|
Hepatitis C virus infection and non-Hodgkin lymphoma: results of the NCI-SEER multi-center case-control study.
|
Int J Cancer
|
2004
|
1.32
|
|
34
|
Gene-nutrient interactions among determinants of folate and one-carbon metabolism on the risk of non-Hodgkin lymphoma: NCI-SEER case-control study.
|
Blood
|
2007
|
1.30
|
|
35
|
Childhood sun exposure influences risk of multiple sclerosis in monozygotic twins.
|
Neurology
|
2007
|
1.29
|
|
36
|
Host immune gene polymorphisms in combination with clinical and demographic factors predict late survival in diffuse large B-cell lymphoma patients in the pre-rituximab era.
|
Blood
|
2008
|
1.26
|
|
37
|
Prevalence of human papillomavirus types in invasive vulvar cancers and vulvar intraepithelial neoplasia 3 in the United States before vaccine introduction.
|
J Low Genit Tract Dis
|
2012
|
1.26
|
|
38
|
Residential herbicide use and risk of non-Hodgkin lymphoma.
|
Cancer Epidemiol Biomarkers Prev
|
2005
|
1.24
|
|
39
|
The relative importance of genetics and environment on mammographic density.
|
Cancer Epidemiol Biomarkers Prev
|
2009
|
1.22
|
|
40
|
Associations between selected biomarkers and prognosis in a population-based pancreatic cancer tissue microarray.
|
Cancer Res
|
2009
|
1.22
|
|
41
|
Vegetables, fruit, and antioxidant-related nutrients and risk of non-Hodgkin lymphoma: a National Cancer Institute-Surveillance, Epidemiology, and End Results population-based case-control study.
|
Am J Clin Nutr
|
2006
|
1.22
|
|
42
|
Census and geographic differences between respondents and nonrespondents in a case-control study of non-Hodgkin lymphoma.
|
Am J Epidemiol
|
2007
|
1.20
|
|
43
|
Immune mechanisms in non-Hodgkin lymphoma: joint effects of the TNF G308A and IL10 T3575A polymorphisms with non-Hodgkin lymphoma risk factors.
|
Cancer Res
|
2007
|
1.17
|
|
44
|
Risk of non-Hodgkin lymphoma associated with germline variation in genes that regulate the cell cycle, apoptosis, and lymphocyte development.
|
Cancer Epidemiol Biomarkers Prev
|
2009
|
1.17
|
|
45
|
Polymorphisms in oxidative stress genes and risk for non-Hodgkin lymphoma.
|
Carcinogenesis
|
2006
|
1.16
|
|
46
|
A population-based description of glioblastoma multiforme in Los Angeles County, 1974-1999.
|
Cancer
|
2005
|
1.16
|
|
47
|
Identification of a panel of sensitive and specific DNA methylation markers for lung adenocarcinoma.
|
Mol Cancer
|
2007
|
1.14
|
|
48
|
Meat and meat-mutagen intake and risk of non-Hodgkin lymphoma: results from a NCI-SEER case-control study.
|
Carcinogenesis
|
2005
|
1.14
|
|
49
|
Spatial-temporal analysis of non-Hodgkin lymphoma in the NCI-SEER NHL case-control study.
|
Environ Health
|
2011
|
1.14
|
|
50
|
Differential twin concordance for multiple sclerosis by latitude of birthplace.
|
Ann Neurol
|
2006
|
1.14
|
|
51
|
Genetic variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2) and risk of non-Hodgkin lymphoma.
|
Pharmacogenet Genomics
|
2006
|
1.12
|
|
52
|
Smoking, alcohol use, obesity, and overall survival from non-Hodgkin lymphoma: a population-based study.
|
Cancer
|
2010
|
1.12
|
|
53
|
Dietary flavonoid intake and lung cancer--a population-based case-control study.
|
Cancer
|
2008
|
1.10
|
|
54
|
A case-control study of occupational exposure to trichloroethylene and non-Hodgkin lymphoma.
|
Environ Health Perspect
|
2011
|
1.10
|
|
55
|
A pooled investigation of Toll-like receptor gene variants and risk of non-Hodgkin lymphoma.
|
Carcinogenesis
|
2008
|
1.08
|
|
56
|
The occurrence of chronic disease and other conditions in a large population-based cohort of native Californian twins.
|
Twin Res
|
2002
|
1.07
|
|
57
|
Residential insecticide use and risk of non-Hodgkin's lymphoma.
|
Cancer Epidemiol Biomarkers Prev
|
2006
|
1.05
|
|
58
|
Human papillomavirus prevalence in oropharyngeal cancer before vaccine introduction, United States.
|
Emerg Infect Dis
|
2014
|
1.04
|
|
59
|
Sun exposure, vitamin D receptor gene polymorphisms and risk of non-Hodgkin lymphoma.
|
Cancer Causes Control
|
2007
|
1.04
|
|
60
|
Metabolic gene variants and risk of non-Hodgkin's lymphoma.
|
Cancer Epidemiol Biomarkers Prev
|
2006
|
1.03
|
|
61
|
Human papillomavirus prevalence in invasive anal cancers in the United States before vaccine introduction.
|
J Low Genit Tract Dis
|
2013
|
1.02
|
|
62
|
Risk patterns of multiple myeloma in Los Angeles County, 1972-1999 (United States).
|
Cancer Causes Control
|
2006
|
1.02
|
|
63
|
Genetic variation in caspase genes and risk of non-Hodgkin lymphoma: a pooled analysis of 3 population-based case-control studies.
|
Blood
|
2009
|
1.01
|
|
64
|
Consortia in cancer epidemiology: lessons from InterLymph.
|
Cancer Epidemiol Biomarkers Prev
|
2007
|
1.00
|
|
65
|
Genetic variation in Th1/Th2 pathway genes and risk of non-Hodgkin lymphoma: a pooled analysis of three population-based case-control studies.
|
Br J Haematol
|
2011
|
0.98
|
|
66
|
Overweight and obesity at different times in life as risk factors for non-Hodgkin's lymphoma: the multiethnic cohort.
|
Cancer Epidemiol Biomarkers Prev
|
2008
|
0.98
|
|
67
|
Gender differences in determinants of smoking initiation and persistence in California twins.
|
Cancer Epidemiol Biomarkers Prev
|
2006
|
0.97
|
|
68
|
Outcome disparities in multiple myeloma: a SEER-based comparative analysis of ethnic subgroups.
|
Br J Haematol
|
2012
|
0.97
|
|
69
|
Environmental determinants of polychlorinated biphenyl concentrations in residential carpet dust.
|
Environ Sci Technol
|
2013
|
0.96
|
|
70
|
Age at last birth in relation to risk of endometrial cancer: pooled analysis in the epidemiology of endometrial cancer consortium.
|
Am J Epidemiol
|
2012
|
0.95
|
|
71
|
Prevalence of human papillomavirus types in invasive cervical cancers from 7 US cancer registries before vaccine introduction.
|
J Low Genit Tract Dis
|
2014
|
0.94
|
|
72
|
Dietary flavonoid intake and non-Hodgkin lymphoma risk.
|
Am J Clin Nutr
|
2008
|
0.93
|
|
73
|
A pooled analysis of three studies evaluating genetic variation in innate immunity genes and non-Hodgkin lymphoma risk.
|
Br J Haematol
|
2011
|
0.93
|
|
74
|
Antibodies to JC and BK viruses among persons with non-Hodgkin lymphoma.
|
Int J Cancer
|
2005
|
0.93
|
|
75
|
Organochlorine exposure, immune gene variation, and risk of non-Hodgkin lymphoma.
|
Blood
|
2008
|
0.92
|
|
76
|
Human papillomavirus genotype prevalence in invasive vaginal cancer from a registry-based population.
|
Obstet Gynecol
|
2014
|
0.91
|
|
77
|
Vegetables- and antioxidant-related nutrients, genetic susceptibility, and non-Hodgkin lymphoma risk.
|
Cancer Causes Control
|
2008
|
0.91
|
|
78
|
Birth order and risk of non-hodgkin lymphoma--true association or bias?
|
Am J Epidemiol
|
2010
|
0.91
|
|
79
|
Associations of non-Hodgkin Lymphoma (NHL) risk with autoimmune conditions according to putative NHL loci.
|
Am J Epidemiol
|
2015
|
0.91
|
|
80
|
Hormone therapy, DNA methylation and colon cancer.
|
Carcinogenesis
|
2010
|
0.91
|
|
81
|
Associations between NBS1 polymorphisms, haplotypes and smoking-related cancers.
|
Carcinogenesis
|
2010
|
0.90
|
|
82
|
Blood transfusion, anesthesia, surgery and risk of non-Hodgkin lymphoma in a population-based case-control study.
|
Int J Cancer
|
2008
|
0.90
|
|
83
|
Relationship between interferon regulatory factor 4 genetic polymorphisms, measures of sun sensitivity and risk for non-Hodgkin lymphoma.
|
Cancer Causes Control
|
2009
|
0.90
|
|
84
|
A case-control study of the association of the polymorphisms and haplotypes of DNA ligase I with lung and upper-aerodigestive-tract cancers.
|
Int J Cancer
|
2008
|
0.89
|
|
85
|
Polymorphisms in DNA repair genes and risk of non-Hodgkin lymphoma in a pooled analysis of three studies.
|
Br J Haematol
|
2010
|
0.89
|
|
86
|
Molecular characteristics of diffuse large B-cell lymphoma in human immunodeficiency virus-infected and -uninfected patients in the pre-highly active antiretroviral therapy and pre-rituximab era.
|
Leuk Lymphoma
|
2013
|
0.89
|
|
87
|
PRRC2A and BCL2L11 gene variants influence risk of non-Hodgkin lymphoma: results from the InterLymph consortium.
|
Blood
|
2012
|
0.89
|
|
88
|
Variations in chromosomes 9 and 6p21.3 with risk of non-Hodgkin lymphoma.
|
Cancer Epidemiol Biomarkers Prev
|
2010
|
0.88
|
|
89
|
Residential proximity to industrial combustion facilities and risk of non-Hodgkin lymphoma: a case-control study.
|
Environ Health
|
2013
|
0.87
|
|
90
|
Risk factors for non-Hodgkin lymphoma subtypes defined by histology and t(14;18) in a population-based case-control study.
|
Int J Cancer
|
2010
|
0.87
|
|
91
|
A pooled analysis of alcohol consumption and risk of multiple myeloma in the international multiple myeloma consortium.
|
Cancer Epidemiol Biomarkers Prev
|
2013
|
0.86
|
|
92
|
High lifetime incidence of adult acute lymphoblastic leukemia among Hispanics in California.
|
Cancer Epidemiol Biomarkers Prev
|
2009
|
0.86
|
|
93
|
Childhood infections and adult height in monozygotic twin pairs.
|
Am J Epidemiol
|
2013
|
0.85
|
|
94
|
Cyclin D1 splice variant and risk for non-Hodgkin lymphoma.
|
Hum Genet
|
2006
|
0.85
|
|
95
|
Smoking, variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2), and risk of non-Hodgkin lymphoma: a pooled analysis within the InterLymph consortium.
|
Cancer Causes Control
|
2012
|
0.85
|
|
96
|
Self-reported history of infections and the risk of non-Hodgkin lymphoma: an InterLymph pooled analysis.
|
Int J Cancer
|
2012
|
0.84
|
|
97
|
Twins as willing research participants: successes from studies nested within the California Twin Program.
|
Twin Res Hum Genet
|
2006
|
0.84
|
|
98
|
Outcome disparities among ethnic subgroups of Waldenström's macroglobulinemia: a population-based study.
|
Oncology
|
2014
|
0.84
|
|
99
|
Multiple myeloma and occupation: a pooled analysis by the International Multiple Myeloma Consortium.
|
Cancer Epidemiol
|
2013
|
0.84
|
|
100
|
Epstein-Barr virus patterns in US Burkitt lymphoma tumors from the SEER residual tissue repository during 1979-2009.
|
APMIS
|
2013
|
0.83
|
|
101
|
Case-control study of simian virus 40 and non-Hodgkin lymphoma in the United States.
|
J Natl Cancer Inst
|
2004
|
0.82
|
|
102
|
Cellular telephones and non-Hodgkin lymphoma.
|
Int J Cancer
|
2006
|
0.81
|
|
103
|
Spatial-temporal analysis of non-Hodgkin lymphoma risk using multiple residential locations.
|
Spat Spatiotemporal Epidemiol
|
2012
|
0.81
|
|
104
|
Variation in effects of non-Hodgkin lymphoma risk factors according to the human leukocyte antigen (HLA)-DRB1*01:01 allele and ancestral haplotype 8.1.
|
PLoS One
|
2011
|
0.80
|
|
105
|
Epigenetic subgroups of esophageal and gastric adenocarcinoma with differential GATA5 DNA methylation associated with clinical and lifestyle factors.
|
PLoS One
|
2011
|
0.80
|
|
106
|
Antibody responses to simian virus 40 T antigen: a case-control study of non-Hodgkin lymphoma.
|
Cancer Epidemiol Biomarkers Prev
|
2005
|
0.80
|
|
107
|
Immunostaining to identify molecular subtypes of diffuse large B-cell lymphoma in a population-based epidemiologic study in the pre-rituximab era.
|
Int J Mol Epidemiol Genet
|
2011
|
0.79
|
|
108
|
A polytomous conditional likelihood approach for combining matched and unmatched case-control studies.
|
Stat Med
|
2010
|
0.79
|
|
109
|
Human leukocyte antigen class I and II alleles and overall survival in diffuse large B-cell lymphoma and follicular lymphoma.
|
ScientificWorldJournal
|
2011
|
0.78
|
|
110
|
Body mass index change in adulthood and lung and upper aerodigestive tract cancers.
|
Int J Cancer
|
2012
|
0.77
|
|
111
|
Atopic allergic conditions and colorectal cancer risk in the Multiethnic Cohort Study.
|
Am J Epidemiol
|
2015
|
0.77
|
|
112
|
Asthma history, occupational exposure to pesticides and the risk of non-Hodgkin's lymphoma.
|
Int J Cancer
|
2006
|
0.77
|
|
113
|
LIM domain only 2 protein expression, LMO2 germline genetic variation, and overall survival in diffuse large B-cell lymphoma in the pre-rituximab era.
|
Leuk Lymphoma
|
2012
|
0.77
|
|
114
|
Inherited genetic variation and overall survival following follicular lymphoma.
|
Am J Hematol
|
2012
|
0.77
|
|
115
|
Tobacco smoking, NBS1 polymorphisms, and survival in lung and upper aerodigestive tract cancers with semi-Bayes adjustment for hazard ratio variation.
|
Cancer Causes Control
|
2013
|
0.76
|
|
116
|
Common immune-related exposures/conditions and risk of non-Hodgkin lymphoma: a case-control study of disease-discordant twin pairs.
|
Am J Epidemiol
|
2015
|
0.76
|
|
117
|
Household endotoxin levels and the risk of non-Hodgkin lymphoma.
|
Cancer Causes Control
|
2013
|
0.75
|
|
118
|
Chromosomal aberrations in peripheral blood lymphocytes and risk for non-Hodgkin lymphoma.
|
J Natl Cancer Inst Monogr
|
2008
|
0.75
|
|
119
|
Hobbies with solvent exposure and risk of non-Hodgkin lymphoma.
|
Cancer Causes Control
|
2007
|
0.75
|
|
120
|
Understanding the asthma epidemic: can twin studies help?
|
Twin Res Hum Genet
|
2008
|
0.75
|